Treatment
0.05% Atropine Eye clinical trials
We’re tracking 8 recruiting studies that include 0.05% Atropine Eye, each written for real people, not researchers, below.
Recruiting studies
- NCT05379855Recruiting
Eye drops for eye alignment and double-vision control in children
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
ShanghaiAges 5–14 - NCT06708156RecruitingPhase 3
Low-dose atropine drops to slow childhood nearsightedness
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hefei, AnhuiAges 6–12 - NCT07028827RecruitingPhase 3
Atropine eye drops for nearsightedness in kids and teens
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
TiranaAges 3–17 - NCT07176949Recruiting
Early myopia prevention study for young children
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
Shanghai, Shanghai MunicipalityAges 3–6 - NCT05667454RecruitingPhase 3
Test atropine eye drops to slow worsening nearsightedness in kids
This Phase 3 trial tests different doses of atropine eye drops to see which dose best slows myopia (nearsightedness) from getting worse in children. It may help by reducing how fast your child’s eyesight changes over time.
Almere StadAges 6–11 - NCT07095894RecruitingPhase 3
Glasses or eye drops for slowing nearsightedness in kids
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
Birmingham, AlabamaAges 5–11 - NCT06282848Recruiting
Myopia treatments for children ages 7 to 9
This study compares different ways to slow down nearsightedness (myopia) in children, including eyedrops and other treatments. It is designed for kids whose vision is getting worse and who are willing to join for 2 years.
Hong KongAges 7–9 - NCT07567040RecruitingPhase 3
Delaying Nearsightedness Onset in Children
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Birmingham, AlabamaAges 6–11
What 0.05% Atropine Eye is being studied for
Conditions with recruiting 0.05% Atropine Eye studies.
Common questions
- Are there clinical trials studying 0.05% Atropine Eye?
- Yes. Clin2 currently lists 8 recruiting studies that include 0.05% Atropine Eye, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a 0.05% Atropine Eye trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is 0.05% Atropine Eye an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether 0.05% Atropine Eye or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.